On 25 July 2013, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...
Apotex Inc.,announced that, as of February 13th, 2015, the FDA has accepted for filing the company's application for Filgrastim [Grastofil],...
STADA Arzneimittel AG has in-licensed a filgrastim product from the largest Canadian owned pharmaceutical company Apotex Inc. The biosimilar, marketed...